Genetic analyses for predictors of radiation response in glioblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 3, 2005, Pages 704-710

  Shih, Helen A ^a   Betensky, Rebecca A ^b   Dorfman, Molly V ^a   Louis, David N ^a   Loeffler, Jay S ^a   Batchelor, Tracy T ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Genetics; Glioblastoma; Predictors; Radiotherapy response

Indexed keywords

GENES; PATIENT MONITORING; RADIOTHERAPY; TUMORS;

GENETIC ANALYSES; PATIENT POPULATION;

GENETIC ENGINEERING;

EPIDERMAL GROWTH FACTOR RECEPTOR; MOLECULAR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME LOSS; CONTROLLED STUDY; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 19; DISEASE-FREE SURVIVAL; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENES, P16; GENES, P53; GENETIC MARKERS; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 25844464196     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.03.059     Document Type: Article

References (34)

1. R. Stupp, P.Y. Dietrich, S. Ostermann Kraljevic Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide J Clin Oncol 20 2002 1375 1382
2. F.G. Barker II, M.L. Simmons, S.M. Chang EGFR overexpression and radiation response in glioblastoma multiforme Int J Radiat Oncol Biol Phys 51 2001 410 418
3. D.N. Louis, A. von Deimling, B.R. Seizinger A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens Am J Pathol 141 1992 777 782
4. J.G. Cairncross, K. Ueki, M.C. Zlatescu Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas J Natl Cancer Inst 90 1998 1473 1479
5. M.P. Rubio, A. von Diemling, D.W. Yandell Accumulation of wild-type p53 protein in human astrocytomas Cancer Res 53 1993 3465 3467
6. K. Ueki, Y. Ono, J.W. Henson CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated Cancer Res 56 1996 150 153
7. Y. Ono, T. Tamiya, T. Ichikawa Malignant astrocytomas with homozygous CDKN2A/p16 gene deletions have higher Ki-67 proliferation indices J Neuropathol Exp Neurol 55 1996 1026 1031
8. D.N. Louis, M.-P. Rubio, K. Correa Molecular genetics of pediatric brain stem gliomas Application of PCR techniques to small and archival brain tumor specimens J Neuropathol Exp Neurol 52 1993 502 515
9. E.A. Maher, F.B. Furnari, R.M. Bachoo Malignant glioma Genetics and biology of a grave matter Genes Dev 15 2001 1311 1333
10. M.L. Simmons, K.R. Lamborn, M. Takahashi Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients Cancer Res 61 2001 1122 1128
11. T. Batchelor, R.A. Betensky, J.M. Esposito Age-dependent prognostic effects of genetic alterations in glioblastoma Clin Cancer Res 10 2004 228 233
12. V.P. Collins Cellular mechanisms targeted during astrocytoma progression Cancer Lett 188 2002 1 7
13. M. Tada, R. Matsumoto, R.D. Iggo Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations Cancer Res 58 1998 1793 1797
14. S. Shiraishi, K. Tada, H. Nakamura Influence of p53 mutations on prognosis of patients with glioblastoma Cancer 95 2002 249 257
15. E. Sharpless, L. Chin The INK4a/ARF locus and melanoma Oncogene 22 2003 3092 3098
16. W. Hilgers, C. Rosty, S.A. Hahn Molecular pathogenesis of pancreatic cancer Hematol Oncol Clin North Am 16 2002 17 35
17. J.A. Kraus, M. Wenghoefer, N. Glesmann TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme J Neurooncol 52 2001 263 272
18. E.W. Newcomb, H. Cohen, S.R. Lee Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes Brain Pathol 8 1998 655 667
19. T. Kamiryo, K. Tada, S. Shiraishi Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme J Neurosurg 96 2002 815 822
20. R. Kirla, E. Salminen, S. Huhtala Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and pRB, and Ki-67 labeling in high grade astrocytomas treated with radiotherapy J Neurooncol 46 2000 71 80
21. N. Shinojima, K. Tada, S. Shiraishi Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res 63 2003 6962 6970
22. J.S. Smith, I. Tachibana, S.M. Passe PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 2001 1246 1256
23. A. Waha, A. Baumann, H.K. Wolf Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-alpha pathway in human astrocytic gliomas J Neurosurg 85 1996 634 641
24. K.D. Aldape, K. Ballman, A. Furth Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance J Neuropathol Exp Neurol 63 2004 700 707
25. W.J. Curran Jr, C.B. Scott, J. Horton Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials J Natl Cancer Inst 85 1993 704 710
26. C.B. Scott, C. Scarantino, R. Urtasun Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients A report using RTOG 90-06 Int J Radiat Oncol Biol Phys 40 1998 51 55
27. E.C. Burton, K.R. Lamborn, B.G. Feuerstein Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma Cancer Res 62 2002 6205 6210
28. A. Rasheed, J.E. Herndon, T.T. Stenzel Molecular markers of prognosis in astrocytic tumors Cancer 94 2002 2688 2697
29. M.C. Schmidt, S. Antweiler, N. Urban Impact of genotype and morphology on the prognosis of glioblastoma J Neuropathol Exp Neurol 61 2002 321 328
30. J. Baxendine-Jones, I. Campbell, D. Ellison p53 status has no prognostic significance in glioblastoma treated with radiotherapy Clin Neuropathol 16 1997 332 336
31. C. Bouvier-Labit, O. Chinot, C. Ochi Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas Neuropathol Appl Neurobiol 24 1998 381 388
32. J.F. Reavey-Cantwell, R.I. Haroun, M. Zahurak The prognostic value of tumor markers in patients with glioblastoma multiforme Analysis of 32 patients and review of the literature J Neurooncol 55 2001 195 204
33. F.G. Barker II, M.D. Prados, S.M. Chang Radiation response and survival time in patients with glioblastoma multiforme J Neurosurg 84 1996 442 448
34. A. Zhu, J. Shaeffer, S. Leslie Epidermal growth factor receptor An independent predictor of survival in astrocytic tumors given definitive irradiation Int J Radiat Oncol Biol Phys 34 1996 809 815